Bifidobacterium bifidum FJSWX19M5 alleviated 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced chronic colitis by mitigating gut barrier injury and increasing regulatory T cells
- 28 November 2022
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 14 (1) , 181-194
Abstract
Probiotics have been evaluated as alternative approaches for preventing the relapse of Crohn's disease (CD). Previously, we observed strain-specific anti-inflammatory properties of Bifidobacterium bifidum in 2,4,6-trinitrobenzene sulfonic acid (TNBS) acute colitis models. In this study, we further assessed the effects of several B. bifidum strains on colonic damage, fibrosis, inflammatory factors, intestinal microbial and metabolic profiles, and peripheral regulatory T cells (Tregs) in the context of TNBS chronic colitis in mice. These results indicated that B. bifidum FJSWX19M5, but not FXJWS17M4, ameliorated body weight loss, reduced colonic shortening and injury, decreased markers of gut inflammation, and rebalanced colonic metabolism in TNBS-treated mice. FJSWX19M5 supplementation also promoted Treg cell differentiation and intestinal barrier restoration compared to other strains. All living B. bifidum strains (FJSWX19M5, FXJWS17M4 and FHENJZ3M6) seemed to restore the disruption of the gut microbiota caused by TNBS. The co-culture of B. bifidum strains and mesenteric lymph node cells from TNBS-treated mice showed that those strains with anti-colitis could induce higher IL-10 levels and a lower ratio of IL-22/IL-10 and IL-17/IL-10 when compared to those strains that were not protective. Furthermore, heat-killed FJSWX19M5 exhibited a relief effect on colitis-related symptoms (including body weight loss, colonic shortening and injury). These data imply that specific B. bifidum strains or their lysates may be the current therapeutic alternatives for CD.Keywords
Funding Information
- National Natural Science Foundation of China (31820103010, 31972971, 32021005)
- Collaborative Innovationcenter of Food Safety and Quality Control in Jiangsu Province
This publication has 50 references indexed in Scilit:
- The Probiotic VSL#3 Has Anti-inflammatory Effects and Could Reduce Endoscopic Recurrence After Surgery for Crohn's DiseaseClinical Gastroenterology and Hepatology, 2015
- Lactosucrose attenuates intestinal inflammation by promoting Th2 cytokine production and enhancing CD86 expression in colitic ratsBioscience, Biotechnology, and Biochemistry, 2015
- Mechanisms of initiation and progression of intestinal fibrosis in IBDScandinavian Journal of Gastroenterology, 2014
- Bifidobacterium bifidum PRL2010 Modulates the Host Innate Immune ResponseApplied and Environmental Microbiology, 2014
- The σ E Pathway Is Involved in Biofilm Formation by Crohn's Disease-Associated Adherent-Invasive Escherichia coliJournal of Bacteriology, 2013
- Protective effects of Ulmus macrocarpa on experimental colitis mice modelsAdvances in Traditional Medicine, 2011
- Characterization of FOXP3+CD4+ regulatory T cells in Crohn's diseaseClinical Immunology, 2007
- High dose probiotic and prebiotic cotherapy for remission induction of active Crohn’s diseaseJournal of Gastroenterology and Hepatology, 2007
- Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn's diseaseJournal of Leukocyte Biology, 2006
- Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent–invasive E. coli strains isolated from patients with Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2003